Atlas Trials

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Clinical trial NCT06299098 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06299098
Sponsor
Regeneron Pharmaceuticals
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2024-03-13
Primary completion
2026-05-06
Enrollment
1005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.